Topic: Parkinson.
Destination: This program will support target validation, pre-clinical and clinical work to foster and accelerate the development of Parkinson’s therapeutics with potential for fundamentally altering disease course or significantly improving management of symptoms.
Budget: $250,000 – $2 million (greater funding may be considered).
Duration:
Llena el siguiente formulario para recibir más información: